Pericyte FAK negatively regulates Gas6/Axl signalling to suppress tumour angiogenesis and tumour growth
Open Access
- 4 June 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Communications
- Vol. 11 (1), 1-14
- https://doi.org/10.1038/s41467-020-16618-6
Abstract
The overexpression of the protein tyrosine kinase, Focal adhesion kinase (FAK), in endothelial cells has implicated its requirement in angiogenesis and tumour growth, but how pericyte FAK regulates tumour angiogenesis is unknown. We show that pericyte FAK regulates tumour growth and angiogenesis in multiple mouse models of melanoma, lung carcinoma and pancreatic B-cell insulinoma and provide evidence that loss of pericyte FAK enhances Gas6-stimulated phosphorylation of the receptor tyrosine kinase, Axl with an upregulation of Cyr61, driving enhanced tumour growth. We further show that pericyte derived Cyr61 instructs tumour cells to elevate expression of the proangiogenic/protumourigenic transmembrane receptor Tissue Factor. Finally, in human melanoma we show that when 50% or more tumour blood vessels are pericyte-FAK negative, melanoma patients are stratified into those with increased tumour size, enhanced blood vessel density and metastasis. Overall our data uncover a previously unknown mechanism of tumour growth by pericytes that is controlled by pericyte FAK. Focal adhesion kinase (FAK) is required for tumour angiogenesis and growth. Here, the authors show that deletion of pericyte FAK upregulates Gas6-Axl mediated Cyr61 production, which increases endothelial cell proliferation and angiogenesis, while elevating tissue factor production to enhance tumour cell proliferation.This publication has 51 references indexed in Scilit:
- MERTK receptor tyrosine kinase is a therapeutic target in melanomaJCI Insight, 2013
- VEGF-Induced Vascular Permeability Is Mediated by FAKDevelopmental Cell, 2012
- Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targetsNature Reviews Drug Discovery, 2011
- Conditional Deletion of the Focal Adhesion Kinase FAK Alters Remodeling of the Blood–Brain Barrier in GliomaCancer Research, 2010
- Endothelial FAK is required for tumour angiogenesisEMBO Molecular Medicine, 2010
- Extracellular Matrix Associated Protein CYR61 is Linked to Prostate Cancer DevelopmentJournal of Urology, 2010
- Macrophage Diversity Enhances Tumor Progression and MetastasisCell, 2010
- Gas6 and the Receptor Tyrosine Kinase Axl in Clear Cell Renal Cell CarcinomaPLOS ONE, 2009
- Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cellsBritish Journal of Cancer, 2008
- Immunobiology of the TAM receptorsNature Reviews Immunology, 2008